1.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007DR2065 EK674, NCT00488384
|
|
2.
|
Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: No age specified
Sponsor: Other
Protocol IDs: 562, NCT00847912
|
|
3.
|
Phase: Phase IV
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2003.333, NCT00133887
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: TROG 05.01, NCT00193895
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 01, NCT00663650
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2007.489/32, NCT00799188
|
|
8.
|
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: oct-MM-2005, Grant # BIOPHOT 26-02-0020, NCT00390351
|
|
9.
|
Phase: Phase II, Phase I
Type: Prevention, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2007-018, NCT00500643
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTL0408, NCT00652080
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: RPCI-DS-96-55, NCI-G97-1224, NCT00002975
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ID02-282, NCT00054691
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-001098-82, NCT00240682
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 19
Sponsor: Other
Protocol IDs: F060106002, NCT00369512
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PEP005-009, NCT00432185
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHORI-2007-016, UCSF-05862, R01-CA-109584, NCT00489086, 05862
|
|
17.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-07070, 7813, 07070, NCT00563290
|
|
18.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 and over
Sponsor: NCI
Protocol IDs: UARIZ-BIO-06182, BIO #06-182, NCT00601640
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTL0108, NCT00604890
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTL0208, NCT00605709
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 - 75
Sponsor: NCI
Protocol IDs: CHORI-2007-022, 05862, CHORI-H473-26042, NCT00783965
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: TASMC - 08 - BC - 270 - CTIL, NCT00781209
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CUV011, NCT00829192
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SHH4476g, NCT00833417
|
